No Data
No Data
No Data
No Data
No Data
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
- Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage
GlobeNewswireApr 26 04:05
Cardiff Oncology Reveals Latest Cancer Research at AACR
TipRanksApr 9 04:23
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 That Supports Ongoing First-line RAS-mutated MCRC Clinical Study
RAS-mutated mCRC – In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor's ability to adapt to hypoxia resulting in a significant decrease in both tumor vascularization and
GlobeNewswireApr 9 04:05
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Yahoo FinanceMar 14 20:08
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersHeron Therapeutics (NASDAQ:HRTX) shares rose 35.4% to $3.19 during Wednesday's regular session. The market value of their outstanding shares is at $479.4 million. The company's, Q4 earnings cam
BenzingaMar 14 01:31
ETRN, CRDF and KC Are Among Pre Market Gainers
Seeking AlphaMar 11 21:30
No Data
No Data